Spending and Out-of-Pocket Prices for Brand-Name Drugs Among Commercially Insured Individuals in Massachusetts, 2015-2017

被引：1
|
作者：
Aaron, Micah B. [1 ]
Sinaiko, Anna D. [2 ]
机构：
[1] Harvard Univ, Hlth Policy Dept, Boston, MA 02115 USA
[2] Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, 677 Huntington Ave,Rm 409, Boston, MA 02115 USA
来源：
JAMA NETWORK OPEN | 2021年 / 4卷 / 03期
关键词：
D O I：
10.1001/jamanetworkopen.2021.3252
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
This cross-sectional study analyzes data on aggregate utilization and aggregate spending by patients and by pharmacy benefit managers to pharmacies for every brand-name drug prescription dispensed to all fully insured patients and some self-insured patients with commercial insurance in Massachusetts from 2015 to 2017.
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Projected spending for brand-name drugs in English primary care given US prices: a cross-sectional study
    Liu, Michael
    MacKenna, Brian
    Feldman, William B.
    Walker, Alex J.
    Avorn, Jerry
    Kesselheim, Aaron S.
    Goldacre, Ben
    [J]. JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 2020, 113 (09) : 350 - 359
  • [32] Rising Use Of Observation Care Among The Commercially Insured May Lead to Total And Out-Of-Pocket Cost Savings
    Adrion, Emily R.
    Kocher, Keith E.
    Nallamothu, Brahmajee K.
    Ryan, Andrew M.
    [J]. HEALTH AFFAIRS, 2017, 36 (12) : 2102 - 2109
  • [33] Out-of-Pocket Cost Burden Associated With Contemporary Management of Advanced Prostate Cancer Among Commercially Insured Patients
    Joyce, Daniel D.
    Sharma, Vidit
    Jiang, David H.
    Van Houten, Holly K.
    Sangaralingham, Lindsey R.
    Borah, Bijan J.
    Kwon, Eugene D.
    Penson, David F.
    Dusetzina, Stacie B.
    Tilburt, Jon C.
    Boorjian, Stephen A.
    [J]. JOURNAL OF UROLOGY, 2022, 208 (05): : 988 - 996
  • [34] INCREASING OUT-OF-POCKET COSTS BY STAGE AMONG COMMERCIALLY INSURED PATIENTS DIAGNOSED WITH CANCER 2016-2020
    McGarvey, N.
    Gitlin, M.
    Fadli, E. S.
    Chung, K. C.
    [J]. VALUE IN HEALTH, 2022, 25 (07) : S362 - S363
  • [35] Out-of-Pocket Spending for Deliveries and Newborn Hospitalizations Among the Privately Insured (vol 148, e2021050552, 2021)
    Chua, K.
    [J]. PEDIATRICS, 2021, 148 (04)
  • [36] Out-of-pocket spending and health care utilization associated with initiation of different medications for opioid use disorder: Findings from a national commercially insured cohort
    Mccann, Nicole C.
    Larochelle, Marc R.
    Morgan, Jake R.
    [J]. JOURNAL OF SUBSTANCE USE & ADDICTION TREATMENT, 2024, 159
  • [37] Hospitalization Expenditures and Out-Of-Pocket Expenses in Patients With Stroke in Northeast China, 2015-2017: A Pooled Cross-Sectional Study
    Ma, Zihua
    Deng, Gongman
    Meng, Zhaolin
    Wu, Huazhang
    [J]. FRONTIERS IN PHARMACOLOGY, 2021, 11
  • [38] Polypharmacy, chemotherapy receipt, and medication-related out-of-pocket costs at end of life among commercially insured adults with advanced cancer
    McDermott, Cara L.
    Curtis, J. Randall
    Sun, Qin
    Fedorenko, Catherine
    Kreizenbeck, Karma
    Ramsey, Scott D.
    [J]. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (04) : 836 - 841
  • [39] Ten-Year Trends in Consumer-Directed Health Plan Enrollment and Out-of-Pocket Costs among Commercially Insured Members with Diabetes
    Garabedian, Laura F.
    Ross-Degnan, Dennis
    Zhang, Fang
    Callahan, Matthew X.
    Lecates, Robert
    Wallace, Jamie
    Soumerai, Stephen B.
    Wharam, James F.
    [J]. DIABETES, 2018, 67
  • [40] Medicare Spending and Potential Savings on Brand-name Drugs With Available Generic Substitutes Excluded by 2 Large Pharmacy Benefit Managers, 2012 Through 2015
    Egilman, Alexander C.
    Wallach, Joshua D.
    Ross, Joseph S.
    Dhruva, Sanket S.
    [J]. JAMA INTERNAL MEDICINE, 2018, 178 (04) : 567 - +
12345